P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 |
CP3A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 |
CP3A4_HUMAN |
Atopic eczema [ICD-11: EA80] |
P08684 |
CP3A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P23141 |
EST1_HUMAN |
Peroxisomal disease [ICD-11: 5C57] |
P23141 |
EST1_HUMAN |
Synthesis disorder [ICD-11: 5C52-5C59] |
P23141 |
EST1_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P23141 |
EST1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P23141 |
EST1_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P23141 |
EST1_HUMAN |
Chronic arterial occlusive disease [ICD-11: BD4Z] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
Q13526 |
PIN1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q13526 |
PIN1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P25779 |
CYSP_TRYCR |
Parasitic worm infestation [ICD-11: 1F90] |
P25779 |
CYSP_TRYCR |
Malaria [ICD-11: 1F40-1F45] |
Q06124 |
PTN11_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P15121 |
ALDR_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P15121 |
ALDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P15121 |
ALDR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15121 |
ALDR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P15121 |
ALDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P15121 |
ALDR_HUMAN |
Cataract [ICD-11: 9B10] |
P15121 |
ALDR_HUMAN |
Glaucoma [ICD-11: 9C61] |
P15121 |
ALDR_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P15121 |
ALDR_HUMAN |
Gout [ICD-11: FA25] |
P15121 |
ALDR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Filariasis [ICD-11: 1F66] |
P09917 |
LOX5_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P09917 |
LOX5_HUMAN |
Lung cancer [ICD-11: 2C25] |
P09917 |
LOX5_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P09917 |
LOX5_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P09917 |
LOX5_HUMAN |
Atopic eczema [ICD-11: EA80] |
P09917 |
LOX5_HUMAN |
Carcinoid syndrome [ICD-11: 5B10] |
P09917 |
LOX5_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
P09917 |
LOX5_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P09917 |
LOX5_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P09917 |
LOX5_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P09917 |
LOX5_HUMAN |
Psoriasis [ICD-11: EA90] |
P09917 |
LOX5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P09917 |
LOX5_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P09917 |
LOX5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P09917 |
LOX5_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P09917 |
LOX5_HUMAN |
Pruritus [ICD-11: EC90] |
P09917 |
LOX5_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P09917 |
LOX5_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P09917 |
LOX5_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P09917 |
LOX5_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P09917 |
LOX5_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P80365 |
DHI2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P80365 |
DHI2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P80365 |
DHI2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P80365 |
DHI2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P80365 |
DHI2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q96KS0 |
EGLN2_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q96KS0 |
EGLN2_HUMAN |
Autism spectrum disorder [ICD-11: 6A02] |
Q96KS0 |
EGLN2_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
Q96KS0 |
EGLN2_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q96KS0 |
EGLN2_HUMAN |
Anemia [ICD-11: 3A00-3A9Z] |
Q9GZT9 |
EGLN1_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q9GZT9 |
EGLN1_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q9GZT9 |
EGLN1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |